ÖÐÎÄÃû³Æ£º Íÿ¹MAPK14 (Phospho-Thr180)¶à¿Ë¡¿¹Ìå
Ó¢ÎÄÃû³Æ£º Anti-MAPK14 (Phospho-Thr180) rabbit polyclonal antibody
±ð Ãû£º RP1-179N16.5; CSBP; CSBP1; CSBP2; CSPB1; EXIP; Mxi2; PRKM14; PRKM15; RK; SAPK2A; p38; P38alpha
Ïà¹ØÀà±ð£º Ò»¿¹
´¢ ´æ£º Àä¶³£¨-20¡æ£© ±Ü¹â
ËÞ Ö÷£º Rabbit
¿¹ Ô£º MAPK14 (Phospho-Thr180)
·´Ó¦ÖÖÊô£º Human, Mouse, Rat
±ê ¼Ç Î Unconjugate
¿Ë¡ÀàÐÍ£º rabbit polyclonal
¼¼Êõ¹æ¸ñ
|
Background: |
Responds to activation by environmental stress, pro-inflammatory cytokines and lipopolysaccharide (LPS) by phosphorylating a number of transcription factors, such as ELK1 and ATF2 and several downstream kinases, such as MAPKAPK2 and MAPKAPK5. Plays a critical role in the production of some cytokines, for example IL-6. May play a role in stabilization of EPO mRNA during hypoxic stress. Isoform Mxi2 activation is stimulated by mitogens and oxidative stress and only poorly phosphorylates ELK1 and ATF2. Isoform Exip may play a role in the early onset of apoptosis. |
|
Applications: |
WB, IHC |
|
Name of antibody: |
MAPK14 (Phospho-Thr180) |
|
Immunogen: |
Synthetic peptide of human MAPK14 (Phospho-Thr180) |
|
Full name: |
mitogen-activated protein kinase 14 (Phospho-Thr180) |
|
Synonyms£º |
RP1-179N16.5; CSBP; CSBP1; CSBP2; CSPB1; EXIP; Mxi2; PRKM14; PRKM15; RK; SAPK2A; p38; P38alpha |
|
SwissProt: |
Q16539 |
|
IHC positive control: |
Human breast carcinoma |
|
IHC Recommend dilution: |
50-100 |
|
WB Predicted band size: |
43 kDa |
|
WB Positive control: |
HT29 cells untreated or treated with UV |
|
WB Recommended dilution: |
500-1000 |


¹ºÎï³µ
°ïÖú
021-54845833/15800441009
